155 related articles for article (PubMed ID: 30562364)
1. Longitudinal changes in the expression of IL-33 and IL-33 regulated genes in relapsing remitting MS.
Sriram S; Shaginurova G; Tossberg JT; Natarajan C; Spurlock CF; Aune TM
PLoS One; 2018; 13(12):e0208755. PubMed ID: 30562364
[TBL] [Abstract][Full Text] [Related]
2. Plasma Interleukin-33 level in relapsing-remitting multiple sclerosis. Is it negatively correlated with central nervous system lesions in patients with mild disability?
Mado H; Adamczyk-Sowa M; Bartman W; Wierzbicki K; Tadeusiak B; Sowa P
Clin Neurol Neurosurg; 2021 Jul; 206():106700. PubMed ID: 34030079
[TBL] [Abstract][Full Text] [Related]
3. A critical role for expression of atypical chemokine receptor 2 in multiple sclerosis: A preliminary project.
Saçmacı H; Sabah Özcan S
Mult Scler Relat Disord; 2020 Feb; 38():101524. PubMed ID: 31770664
[TBL] [Abstract][Full Text] [Related]
4. Increased levels of IL-15 mRNA in relapsing--remitting multiple sclerosis attacks.
Blanco-Jerez C; Plaza JF; Masjuan J; Orensanz LM; Alvarez-Cermeño JC
J Neuroimmunol; 2002 Jul; 128(1-2):90-4. PubMed ID: 12098515
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-33 plasma levels in patients with relapsing-remitting multiple sclerosis.
Alsahebfosoul F; Rahimmanesh I; Shajarian M; Etemadifar M; Sedaghat N; Hejazi Z; Naderi S
Biomol Concepts; 2017 Mar; 8(1):55-60. PubMed ID: 28107165
[TBL] [Abstract][Full Text] [Related]
6. Micro-RNA-96 and interleukin-10 are independent biomarkers for multiple sclerosis activity.
Sedeeq MS; El-Nahrery EMA; Shalaby N; Hussein M; Shehata H; El Aal RA; Abdel Ghaffar NF; Mohamed MM
J Neurol Sci; 2019 Aug; 403():92-96. PubMed ID: 31238191
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 1 receptor antagonist and 2'-5'-oligoadenylate synthetase-like molecules as novel biomarkers for multiple sclerosis patients in Bahrain.
Al-Nashmi M; Taha S; Alsharoqi I; Bakhiet M
Mult Scler Relat Disord; 2017 Nov; 18():1-7. PubMed ID: 29141788
[TBL] [Abstract][Full Text] [Related]
8. Micro-RNA 18b and interleukin 17A profiles in relapsing remitting multiple sclerosis.
Mohamed MS; Nahrery EMAE; Shalaby N; Hussein M; Aal RAE; Mohamed MM
Mult Scler Relat Disord; 2019 Feb; 28():226-229. PubMed ID: 30623862
[TBL] [Abstract][Full Text] [Related]
9. Untreated relapsing remitting multiple sclerosis patients show antibody production against latent Epstein Barr Virus (EBV) antigens mainly in the periphery and innate immune IL-8 responses preferentially in the CNS.
Sisay S; Lopez-Lozano L; Mickunas M; Quiroga-Fernández A; Palace J; Warnes G; Alvarez-Lafuente R; Dua P; Meier UC
J Neuroimmunol; 2017 May; 306():40-45. PubMed ID: 28385186
[TBL] [Abstract][Full Text] [Related]
10. Profiling of Canonical and Non-Traditional Cytokine Levels in Interferon-β-Treated Relapsing-Remitting-Multiple Sclerosis Patients.
D'Angelo C; Reale M; Costantini E; Di Nicola M; Porfilio I; de Andrés C; Fernández-Paredes L; Sánchez-Ramón S; Pasquali L
Front Immunol; 2018; 9():1240. PubMed ID: 29915590
[TBL] [Abstract][Full Text] [Related]
11. A longitudinal observation of brain-derived neurotrophic factor mRNA levels in patients with relapsing-remitting multiple sclerosis.
Liguori M; Fera F; Patitucci A; Manna I; Condino F; Valentino P; Telarico P; Cerasa A; Gioia MC; di Palma G; Quattrone A
Brain Res; 2009 Feb; 1256():123-8. PubMed ID: 19071096
[TBL] [Abstract][Full Text] [Related]
12. The Validation Study of Neurofilament Heavy Chain and 8-hydroxy-2'-deoxyguanosine as Plasma Biomarkers of Clinical/Paraclinical Activity in First and Relapsing-Remitting Demyelination Acute Attacks.
Ljubisavljevic S; Stojanovic I; Basic J; Pavlovic DA
Neurotox Res; 2016 Oct; 30(3):530-8. PubMed ID: 27295058
[TBL] [Abstract][Full Text] [Related]
13. Interleukins 17 and 10 in a sample of Egyptian relapsing remitting multiple sclerosis patients.
Tawfik TZ; Gad AH; Mehaney DA; El Nahrery E; Shehata HS; Hashem H; Ghaffar NFA; Shalaby N
J Neurol Sci; 2016 Oct; 369():36-38. PubMed ID: 27653861
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Interleukin-17A, Interleukin-10 and Transforming Growth Factor-Beta1 Serum Titers in Relapsing Remitting Multiple Sclerosis Patients Treated with Avonex, Possible Biomarkers for Treatment Response.
Balasa R; Maier S; Voidazan S; Hutanu A; Bajko Z; Motataianu A; Tilea B; Tiu C
CNS Neurol Disord Drug Targets; 2017; 16(1):93-101. PubMed ID: 27306062
[TBL] [Abstract][Full Text] [Related]
15. Optical coherence tomography segmentation analysis in relapsing remitting versus progressive multiple sclerosis.
Behbehani R; Abu Al-Hassan A; Al-Salahat A; Sriraman D; Oakley JD; Alroughani R
PLoS One; 2017; 12(2):e0172120. PubMed ID: 28192539
[TBL] [Abstract][Full Text] [Related]
16. Clinical and laboratory study of pro-inflammatory and antiinflammatory cytokines in women with multiple sclerosis.
Trenova AG; Manova MG; Kostadinova II; Murdjeva MA; Hristova DR; Vasileva TV; Zahariev ZI
Folia Med (Plovdiv); 2011; 53(2):29-35. PubMed ID: 21797104
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor-alfa and interleukin-4 in cerbrospinal fluid and plasma in different clinical forms of multiple sclerosis.
Obradović D; Kataranovski M; Dincić E; Obradović S; Colić M
Vojnosanit Pregl; 2012 Feb; 69(2):151-6. PubMed ID: 22500369
[TBL] [Abstract][Full Text] [Related]
18. Distinct pattern of lesion distribution in multiple sclerosis is associated with different circulating T-helper and helper-like innate lymphoid cell subsets.
Gross CC; Schulte-Mecklenbeck A; Hanning U; Posevitz-Fejfár A; Korsukewitz C; Schwab N; Meuth SG; Wiendl H; Klotz L
Mult Scler; 2017 Jun; 23(7):1025-1030. PubMed ID: 27481205
[TBL] [Abstract][Full Text] [Related]
19. Phospholipase D1 expression analysis in relapsing-remitting multiple sclerosis patients.
Eftekharian MM; Azimi T; Ghafouri-Fard S; Sayad A; Omrani MD; Sarrafzadeh S; Abbasalipourkabir R; Mazdeh M; Taheri M
Neurol Sci; 2017 May; 38(5):865-872. PubMed ID: 28229303
[TBL] [Abstract][Full Text] [Related]
20. Immune and Epstein-Barr virus gene expression in cerebrospinal fluid and peripheral blood mononuclear cells from patients with relapsing-remitting multiple sclerosis.
Veroni C; Marnetto F; Granieri L; Bertolotto A; Ballerini C; Repice AM; Schirru L; Coghe G; Cocco E; Anastasiadou E; Puopolo M; Aloisi F
J Neuroinflammation; 2015 Jul; 12():132. PubMed ID: 26169064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
